Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
NUCYNTA® (tapentadol) is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older.
- generic_name
- tapentadol hydrochloride
- product_names
- tapentadol hydrochloride
- ndc
- 54868-5979, 50458-820, 54868-5979-0, 54868-5979-1, 54868-6002, 50458-830, 54868-6002-0, 54868-6039, 50458-840, 54868-6039-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en